氨甲环酸用于轻中度创伤性脑损伤是安全的
CRASH-3是一项随机、安慰剂对照试验,评估氨甲环酸对急性创伤性脑损伤患者死亡、残疾、血管闭塞事件及其他并发症的影响。该试验由NIHR Health Technology Assessment Programme等资助。NIHR Signal指出,氨甲环酸用于轻中度创伤性脑损伤是安全的,并可降低死亡。
要点
- CRASH-3试验为随机、安慰剂对照试验,评估氨甲环酸对急性创伤性脑损伤患者死亡、残疾、血管闭塞事件及其他并发症的影响。
- NIHR Signal结论:氨甲环酸用于轻中度创伤性脑损伤是安全的,并可降低死亡。
- 该试验由NIHR Health Technology Assessment Programme(项目编号14/190/01)、JP Moulton Charitable Trust、Department of Health and Social Care、Department for International Development、Global Challenges Research Fund
适用人群与场景
- 急性创伤性脑损伤患者,具体纳入人群为轻中度创伤性脑损伤患者(据NIHR Signal标题及结论)。
研究设计与关键结果
- CRASH-3为随机、安慰剂对照试验,评估氨甲环酸对急性创伤性脑损伤患者死亡、残疾、血管闭塞事件及其他并发症的影响(Lancet 2019;394:1713-23)。
- NIHR Signal指出,氨甲环酸用于轻中度创伤性脑损伤是安全的,并可降低死亡。
证据类型、等级与局限
- 证据类型:随机、安慰剂对照试验(CRASH-3)。
- 局限:原文未报告局限性
对床旁实践的改变
- NIHR Signal结论认为,氨甲环酸用于轻中度创伤性脑损伤是安全的,并可降低死亡。
指南或共识出处
- CRASH-3 Trial Collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 2019;394:1713-23.
- NIHR Signal: Tranexamic acid following mild-to-moderate traumatic brain injury is safe and reduces deaths.
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The studyThe CRASH-3 Trial Collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 2019;394:1713-23.This trial was funded by NIHR Health Technology Assessment Programme (project number 14/190/01), JP Moulton Charitable Trust, Department of Health and Social Care, Department for International Development, Global Challenges Research Fund, Medical Research Council, and the Wellcome Trust (Joint Global Health Trials scheme).To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000870/tranexamic-acid-following-mild-to-moderate-traumatic-brain-injury-is-safe-and-reduces-deaths.
参考来源
- Cook R, Lyon-Maris J, Martin R, et al. Tranexamic acid is safe to use following mild-to-moderate traumatic brain injury. BMJ. 2020. PMID: 32161036. doi:10.1136/bmj.m514
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。